New Possibilities for Approved Drugs

With over 25 years of experience in pharma product development and commercialization, Vatsa has contributed to 15 NDAs, 25+ INDs, and several marketed therapies. A serial entrepreneur and seasoned R&D leader, he brings deep expertise across global organizations including Vertex, PPD, Glenmark, DRL Aurigene, Sapien (a JV with Apollo Hospitals), and Rhizen. Vatsa excels at converting complex scientific ideas into viable businesses by building high-performance teams.

With over 25 years of cross-functional experience in pharma development, Kiran has led regulatory, CMC, and portfolio strategy initiatives across global markets. He has contributed to more than 75 ANDAs, multiple sNDAs, INDs, and pre-IND programs. A strategic thinker with deep regulatory expertise, Kiran has held leadership roles at Rising/Citron, Casper, Cosette, Austar Pharma, Sciecure, and URL Mutual. He brings a unique ability to integrate science, compliance, and commercialization to build sustainable product pipelines.

With nearly 20 years in pharmaceutical formulation and clinical development, Vinayak has successfully brought innovative and first-to-file products to global markets. A serial entrepreneur, he developed over 20 formulations, including 505(b)(2) products. Before founding Revio, he built Novick Biosciences into a leading CRO and held key roles at Sanofi, GSK, and Quintiles.

With over 20 years of experience spanning technology, finance, and investment, Jyothi brings a unique perspective to applying AI in pharma. He has served as an investor, portfolio manager, sell-side analyst, and startup founder, with deep expertise in productizing AI for domain-specific B2B applications. Before co-founding Revio, He bridges data, technology, and strategy to build scalable AI platforms that enhance decision-making and operational efficiency.